RegisterLogin

BML-265

CAT: 0804-HY-169948Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-169948Size:1 Each
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BML-265 is a potent EGFR tyrosine kinase inhibitor. BML-265 disrupts Golgi integrity and abolishes secretory protein transport of diverse cargos. BML-265 affects Golgi integrity and transport in human cells but not in rodent cells[1].
CAS Number
[183321-62-2]
UNSPSC
12352005
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
COC1=C(OC)C=C(N=CN=C2NC3=CC=CC(C#C)=C3)C2=C1
Molecular Formula
C18H15N3O2
Molecular Weight
305.33
References & Citations
[1]Boncompain G, et al. BML-265 and Tyrphostin AG1478 Disperse the Golgi Apparatus and Abolish Protein Transport in Human Cells. Front Cell Dev Biol. 2019 Oct 11;7:232.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-108348-01BML-259
HY-W025074-01BML-278
HY-133095-01BML-260
HY-114023BML-288
HY-13946-01BML-277
HY-19987-01BML-284
HY-113721BML-244
HY-100450-01BML-111
HY-19350-01BML-210
HY-15420-01BML-190

Alternative Products

CatalogName
T204769-01BML-265
MBS131442BML-210, (BML210; BML 210)
MBS131522BML-284 (BML 284; BML284)
200770RAF-265 (CHIR-265)
M28107-01BML-259
M18363-01BML-190
T68558-01BML-288
MBS565614-01BML-284
262826-01BML-286
T3144-01BML-284

Popular Products